• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体制剂作为超饱和口服递药系统:从当前到未来的工业应用。

Lipid based formulations as supersaturating oral delivery systems: From current to future industrial applications.

机构信息

Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Denmark.

University of Applied Sciences and Arts Northwestern Switzerland, Institute of Pharmaceutical Technology, Hofackerstr. 30, CH-4132 Muttenz, Switzerland.

出版信息

Eur J Pharm Sci. 2023 Oct 1;189:106556. doi: 10.1016/j.ejps.2023.106556. Epub 2023 Aug 4.

DOI:10.1016/j.ejps.2023.106556
PMID:37543063
Abstract

Lipid-based formulations, in particular supersaturated lipid-based formulations, are important delivery approaches when formulating challenging compounds, as especially low water-soluble compounds profit from delivery in a pre-dissolved state. In this article, the classification of lipid-based formulation is described, followed by a detailed discussion of different supersaturated lipid-based formulations and the recent advances reported in the literature. The supersaturated lipid-based formulations discussed include both the in situ forming supersaturated systems as well as the thermally induced supersaturated lipid-based formulations. The in situ forming drug supersaturation by lipid-based formulations has been widely employed and numerous clinically available products are on the market. There are some scientific gaps in the field, but in general there is a good understanding of the mechanisms driving the success of these systems. For thermally induced supersaturation, the technology is not yet fully understood and developed, hence more research is required in this field to explore the formulations beyond preclinical studies and initial clinical trials.

摘要

脂质体制剂,特别是过饱和脂质体制剂,是在对具有挑战性的化合物进行制剂时的重要给药途径,因为特别是低水溶性的化合物可以从溶解前的状态下得到受益。本文描述了脂质体制剂的分类,然后详细讨论了不同的过饱和脂质体制剂以及文献中报道的最新进展。讨论的过饱和脂质体制剂包括原位形成的过饱和系统以及热诱导的过饱和脂质体制剂。通过脂质体制剂的药物原位形成过饱和已得到广泛应用,并且市场上有许多临床可用的产品。该领域存在一些科学空白,但总体而言,人们对这些系统成功的驱动机制有了很好的理解。对于热诱导过饱和,该技术尚未得到充分的理解和开发,因此该领域需要更多的研究来探索超越临床前研究和初步临床试验的制剂。

相似文献

1
Lipid based formulations as supersaturating oral delivery systems: From current to future industrial applications.脂质体制剂作为超饱和口服递药系统:从当前到未来的工业应用。
Eur J Pharm Sci. 2023 Oct 1;189:106556. doi: 10.1016/j.ejps.2023.106556. Epub 2023 Aug 4.
2
The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.固化对载有布南色林的过饱和脂质基口服制剂体外溶解的影响
Eur J Pharm Sci. 2021 Feb 1;157:105640. doi: 10.1016/j.ejps.2020.105640. Epub 2020 Nov 13.
3
Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.辛尼嗪从 II 型脂质体制剂中的吸收:脂质链长、过饱和度、消化和沉淀抑制的影响。
Eur J Pharm Sci. 2024 Jun 1;197:106765. doi: 10.1016/j.ejps.2024.106765. Epub 2024 Apr 10.
4
Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.消化是从超饱和脂质型 I 制剂中吸收肉桂嗪的关键因素。
Eur J Pharm Sci. 2024 Jan 1;192:106634. doi: 10.1016/j.ejps.2023.106634. Epub 2023 Nov 10.
5
, , and Evaluation of Precipitation Inhibitors in Supersaturated Lipid-Based Formulations of Venetoclax.,, 和 评价 Venetoclax 在过饱和脂质体制剂中的沉淀抑制剂。
Mol Pharm. 2021 Jun 7;18(6):2174-2188. doi: 10.1021/acs.molpharmaceut.0c00645. Epub 2021 Apr 23.
6
Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad membrane and in vivo absorption.探索塞来昔布的超饱和脂质体药物递送系统对其体外透过Permeapad膜的渗透及体内吸收的影响。
Eur J Pharm Sci. 2020 Sep 1;152:105452. doi: 10.1016/j.ejps.2020.105452. Epub 2020 Jul 3.
7
Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems.探索沉淀抑制剂以提高辛尼嗪从超饱和脂质给药系统的体内吸收。
Eur J Pharm Sci. 2021 Apr 1;159:105691. doi: 10.1016/j.ejps.2020.105691. Epub 2020 Dec 24.
8
Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading.超饱和硅脂质杂化物(super-SLH):一种改良的固态脂质基口服药物传递系统,可增强药物载药量。
Eur J Pharm Biopharm. 2018 Apr;125:13-20. doi: 10.1016/j.ejpb.2017.12.012. Epub 2017 Dec 22.
9
Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.基于脂质的系统作为提高难溶性药物生物利用度的一种有前景的方法。
Acta Pharm. 2013 Dec;63(4):427-45. doi: 10.2478/acph-2013-0040.
10
Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.用于口服难溶性药物的基于脂质的制剂设计:制剂在水溶液中分散后药物的沉淀。
J Pharm Sci. 2009 Oct;98(10):3582-95. doi: 10.1002/jps.21659.

引用本文的文献

1
Application of Solvent Evaporation to Generate Supersaturated Lipid-Based Formulations: Investigation of Drug Load and Formulation Quality.溶剂蒸发法在制备过饱和脂质制剂中的应用:药物载量与制剂质量研究
Pharmaceutics. 2025 May 27;17(6):702. doi: 10.3390/pharmaceutics17060702.
2
Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid-A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends.自乳化药物递送系统(SEDDS):从液体到固体的转变——制剂、表征、应用及未来趋势的全面综述
Pharmaceutics. 2025 Jan 5;17(1):63. doi: 10.3390/pharmaceutics17010063.
3
Ketoconazole-Fumaric Acid Pharmaceutical Cocrystal: From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation.
酮康唑-富马酸药物共晶体:从提高生物利用度的制剂设计到生物相容性测试和抗真菌疗效评估
Int J Mol Sci. 2024 Dec 12;25(24):13346. doi: 10.3390/ijms252413346.
4
Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids.探索脂质纳米颗粒(LNPs)的全貌:对LNPs类型及脂质生物来源的全面综述
Int J Pharm X. 2024 Nov 18;8:100305. doi: 10.1016/j.ijpx.2024.100305. eCollection 2024 Dec.
5
Thermally-Induced Supersaturation Approach for Optimizing Drug Loading and Biopharmaceutical Properties of Supersaturated Lipid-Based Formulations: Case Studies with Ibrutinib and Enzalutamide.热致过饱和法优化脂质体载药及生物药剂学性质:以伊布替尼和恩杂鲁胺为例
AAPS PharmSciTech. 2024 Aug 20;25(7):192. doi: 10.1208/s12249-024-02912-9.
6
Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax.合理选择反离子以开发亲脂性盐:以 Venetoclax 为例的案例研究。
Mol Pharm. 2024 Jun 3;21(6):2981-2992. doi: 10.1021/acs.molpharmaceut.4c00106. Epub 2024 May 4.
7
Phospholipid Complex Formulation Technology for Improved Drug Delivery in Oncological Settings: a Comprehensive Review.磷脂复合物制剂技术在肿瘤治疗中的药物递送改善作用:全面综述。
AAPS PharmSciTech. 2024 Apr 25;25(5):91. doi: 10.1208/s12249-024-02813-x.
8
Repaglinide-Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box-Behnken Design, Characterization, and In Vivo Evaluation.瑞格列奈固体脂质纳米粒壳聚糖贴片经皮给药:Box-Behnken 设计、表征和体内评价。
Int J Nanomedicine. 2024 Jan 10;19:209-230. doi: 10.2147/IJN.S438564. eCollection 2024.